Laryngectomy Clinical Trials

Clinical trials related to Laryngectomy Procedure

Post-operative Use of the New Adhesive After Total Laryngectomy

Status: Recruiting
Location: See all (3) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to evaluate the feasibility, safety, and performance of the new adhesive when used in the immediate post-operative period after total laryngectomy. The main question it aims to answer is: \- Is the adhesive feasible and safe to use during the early post-operative phase? This is a single-arm feasibility study with historical controls, so there is no concurrent comparison group. Researchers will compare outcomes to historical data from standard adhesive use to assess improvements in tolerance and skin condition. Participants will: * Use the adhesive as part of their standard post-laryngectomy care. * Complete patient-reported outcome questionnaires (e.g., comfort, skin assessment, satisfaction). * Allow investigators to record observations in diaries and patient charts. * Participate in routine clinical assessments during hospitalization and at end of study (approximately 30 days post-surgery).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patient undergoing total laryngectomy surgery

• 18 years or older

Locations
Other Locations
Netherlands
Antoni van Leeuwenhoek, Netherlands Cancer Institute
NOT_YET_RECRUITING
Amsterdam
University Medical Center Groningen
NOT_YET_RECRUITING
Groningen
Maastricht University Medical Center
RECRUITING
Maastricht
Time Frame
Start Date: 2026-08-30
Estimated Completion Date: 2027-08
Participants
Target number of participants: 25
Treatments
Experimental: Exploratory post-operative use of Comfort Adhesive
Participants will start using a newly developed adhesive called Provox Life Comfort Adhesive in the immediate post-operative period following total laryngectomy.
Related Therapeutic Areas
Sponsors
Leads: Atos Medical AB

This content was sourced from clinicaltrials.gov